SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002651
Filing Date
2019-04-29
Accepted
2019-04-29 06:05:10
Documents
10
Period of Report
2019-06-26
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238579zdef14a.htm DEF 14A 1264198
2 G202915.JPG g202915.jpg GRAPHIC 17152
3 G1012795.JPG g1012795.jpg GRAPHIC 6628
4 G588654.JPG g588654.jpg GRAPHIC 30570
5 G890392.JPG g890392.jpg GRAPHIC 31381
6 G705914.JPG g705914.jpg GRAPHIC 207066
7 G25812DA01I001.GIF g25812da01i001.gif GRAPHIC 182831
8 G25812DA01I002.GIF g25812da01i002.gif GRAPHIC 304222
9 G25812DA03I001.GIF g25812da03i001.gif GRAPHIC 209109
10 G25812DA03I002.GIF g25812da03i002.gif GRAPHIC 268473
  Complete submission text file 0001047469-19-002651.txt   2997804
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26301 | Film No.: 19773563
SIC: 2834 Pharmaceutical Preparations